Literature DB >> 33770184

Risk Factors for the Acquisition of a blaNDM-5 Carbapenem-Resistant Escherichia coli in a Veterinary Hospital.

Sondra H Lavigne, Stephen D Cole, Carolann Daidone, Shelley C Rankin.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are an urgent antibiotic resistant threat. Only sporadic reports of CRE in companion animals have been described. Our objective was to identify risk factors associated with the acquisition of a blaNDM-5 CR-Escherichia coli strain as part of an outbreak investigation at a tertiary veterinary hospital in the United States. A matched case-control study was conducted among companion animals admitted during July 1, 2018, through June 30, 2019. The 15 identified blaNDM-5 CR-E coli cases were matched 1:2 with controls (culture negative for blaNDM-5 CR-E coli) based on species and number of days of hospitalization before bacterial culture sample collection. The association between exposure to various procedures and hospital services and the acquisition of blaNDM-5 CR-E. coli was assessed through conditional logistic regression. Case patients had significantly higher odds of exposure to the anesthesia service (odds ratio [OR] = 12.8, P = .017), the surgical service (OR = 4.0, P = .046), and to endotracheal intubation (OR = 10.0, P = .03). Veterinary hospitals should be aware of the potential for transmission of CRE via anesthetic and surgical procedures, especially those that require the placement of endotracheal tubes.
© 2021 by American Animal Hospital Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33770184     DOI: 10.5326/JAAHA-MS-7105

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.146


  1 in total

1.  A Survey of Current Activities and Technologies Used to Detect Carbapenem Resistance in Bacteria Isolated from Companion Animals at Veterinary Diagnostic Laboratories-United States, 2020.

Authors:  Michelle A Waltenburg; Alicia Shugart; John Dustin Loy; Deepanker Tewari; Shuping Zhang; Stephen D Cole; Maroya Spalding Walters; Megin Nichols
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 11.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.